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ABSTRACT
The gastric remnant cancer is defined as a cancer that has developed 5 or more years after distal gastric 
resection for benign diseases of the stomach. The choriocarcinomatous differentiation of adenocarcinoma 
in the stomach is a very rare tumor. A 75-year-old woman underwent resection of remnant stomach 
which she had operated for benign gastric pathology 54 years ago. Pathologic examination of the resec-
tion revealed areas of choriocarcinomatous differentiation in addition to classical adenocarcinoma. In 
the literature on English language, this report presents the first case of adenocarcinoma associated with 
choriocarcinomatous differentiation in the gastric remnant. The treatment of these patients depends on 
the clinical setting, and early diagnosis is an important factor for the treatment strategies. Therefore, due 
to the probability of arising adenocarcinoma in the remnant stomach, the patient should be investigated 
with endoscopic examination periodically, despite the long postoperative period.
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INTRODUCTION
The gastric remnant cancer (GRC) is defined as a 
carcinoma that arises in the stomach remnant fol-
lowing previous partial gastrectomy for benign dis-
eases. The length of time after operation is important 
for the diagnosis of remnant cancer and it is usually 
defined as a cancer that has developed after 5 years 
of subtotal gastrectomy (1,2). Adenocarcinomas 
with choriocarcinomatous differentiation are very ???????????????????????????????????????????????? © 2016 Mehmet Yildirim et al.; licensee University of Sarajevo - Faculty of Health Studies. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distri-
bution, and reproduction in any medium, provided the original work is properly cited.
rare in the gastrointestinal tract. Pure choriocarci-
nomas or carcinomas associated with choriocar-
cinomatous areas are most commonly seen in the 
uterus, followed by the gonads, mediastinum, ret-
roperitoneum, and rarely in the stomach and rem-
nant stomach. Primary gastric choriocarcinoma was 
first reported by Davidson in 1905 and accounts 
for 0.08% of all primary gastric cancers (3). To our 
knowledge, there have been no published reports 
concerning the choriocarcinomatous differentiation 
of adenocarcinoma in the gastric remnant.
In this report we present a case of GRC with his-
tology of adenocarcinoma with choriocarcinoma-
tous differentiation in the gastric remnant after the 
patient had undergone a Billroth II subtotal gastrec-
tomy 54 years earlier.
*Corresponding author: Mehmet Yildirim, Department of Surgery, 
Izmir Bozyaka Education and Research Hospital, Atakent Mah, 
Bergama 2 Apt,32/1, Bostanli, Izmir, Turkey, Tel.: 0090 532 
2855557. E-mail: mehmetyildi@gmail.com
Submitted: 24 April 2016/Accepted: 06 May 2016
DOI: http://dx.doi.org/10.17532/jhsci.2016.352
CASE REPORT Open Access
http://www.jhsci.ba Mehmet Yildirim, et al. Journal of Health Sciences 2016;6(2):133-136
134
CASE REPORT
A 75-year-old woman was admitted to our Surgical 
Department with vague epigastric pain. She had 
a history of a subtotal gastrectomy with Billroth 
II reconstruction for a benign condition approx-
imately 54  years ago. She had no clinicopath-
ological complaints and there was no endoscopic 
follow-up of upper gastrointestinal tract during 
this 54-year period. Laboratory findings were unre-
markable. There was no evidence of gastric thicken-
ing or tumoral mass at computerized tomography. 
No pathological findings were found in the other 
intra-abdominal organ systems, including the gen-
ital system. Upper gastrointestinal endoscopy visu-
alized an ulcerated polypoid lesion with the largest 
size of 0.6 cm at the anastomotic line (Figure 1) and 
the histological diagnosis of endoscopic biopsy was 
adenocarcinoma.
The patient underwent a total gastrectomy with 
Roux-en-Y esophagojejunostomy reconstruc-
tion as the gastric mass was found just above the 
anastomosis line extending to the subserosal layer. 
Macroscopic pathological examination revealed 
irregular tumor mass with ulcerative growth pat-
tern largest size of 4 cm and multiple hemorrhagic 
and necrotic foci were seen at the anastomosis 
line (Figure  2). On the cut surface, the central of 
the tumor was hemorrhagic and necrotic and the 
peripheral zone of the tumor mass was whitish-gray 
colored. Microscopically, the tumor had two com-
ponents (Figure 3A and 3B). The first component 
was a moderately differentiated adenocarcinoma, 
accounting for approximately 70% of the entire 
tumor sections and the second component had 
highly pleomorphic appearance and was accounting 
for approximately 30% of the entire tumor. There 
were highly pleomorphic cells associated with many 
syncytiotrophoblast-like cells with bizarre nuclei, 
especially in the hemorrhagic areas. Histological 
features of this component were consistent with 
choriocarcinoma. Immunohistochemically, syncy-
tiotrophoblast-like cells and some highly pleomor-
phic cells were strongly positive for beta Human 
Chorionic Gonadotropin antibody (β-hCG) 
(Figure  4). However, there was no staining in the 
classical moderately differentiated adenocarci-
nomatous component for the β-hCG antibody. 
Immunohistochemically, neoplastic cells were dif-
fusely positive for CK7 (cytokeratin) and pancy-
tokeratin, focal mild positive for PLAP (Placental 
Alkaline Phosphatase) antibody and hPL (human 
placental lactogen), and negative for vimentin. Based 
on these histopathological findings, we diagnosed 
the lesion as gastric adenocarcinoma with chorio-
carcinomatous differentiation. Histopathologically, 
the tumor infiltrated the subserosal area and was 
classified as pathological tumor stage T3. There was 
no spread to the lymph nodes (0/21) and there was 
no lymphovascular/perineural invasion. The patient 
was considered clinically stage IIA. Postoperative 
FIGURE 1. The endoscopic shape of the lesion shows a polypoid 
lesion with central ulceration (arrow).
FIGURE 2. Macroscopic examination shows ulcerated tumor at 
the anastomosis line (large arrow: efferent loop; small arrow: affer-
ent loop; yellow arrow: ulcer).
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laboratory findings revealed the β-hCG level of 
6.7 mIU/ml (normal level is under 5). After a year 
follow-up, there was no evidence for recurrent dis-
ease. Furthermore the β-hCG levels were within 
normal limits.
DISCUSSION
Cancer in the remnant stomach was classified into 
three types by Tanigawa, including a new developed 
cancer, remaining cancer at the primary opera-
tion (residual cancer), and recurrent cancer. Later, 
Kaminishi described a newly cancer as a cancer 
developed more than 10 years after partial gastrec-
tomy for benign or malignant disease (4). Also, a 
definition of a recurrent or residual cancer means 
that the cancer has developed less than 10 years after 
the surgery of the gastric malignancy. In the liter-
ature, the time between the operation and appear-
ing GRC is between 5 and 40 years. According to 
this classification, our case was classified as a newly 
developed cancer in the remnant stomach. GRC is 
mostly observed around the gastroenterostomy line, 
and the pancreaticobiliary reflux may be the trigger 
for etiopathogenetic process of developing GRC. 
Because the clinical and laboratory findings of GRC 
are nonspecific at the early stage, these tumors are 
commonly presented at later stages. According to 
the Japanese Research Society of Gastric Cancer, 
nearly 30% of the newly developed cancers were 
found as differentiated adenocarcinoma. The major-
ity of these tumors are adenocarcinomas, and the 
reports of classical adenocarcinoma associated with 
choriocarcinomatous differentiation are very rare.
A theory indicating a relationship with degenera-
tion of a gastric teratoma has not been proven. The 
precise pathogenesis has not been clear, but several 
mechanisms including dedifferentiation of gastric 
adenocarcinoma, degeneration of gastric teratoma, 
or gonadal origin have been proposed. The chorio-
carcinomatous differentiation basically consists of 
cytotrophoblastic and syncytiotrophoblastic cells. 
Histopathological findings of the gastric biopsy are 
extremely elusive because small biopsy specimens 
are not adequate for accurate diagnosis. In this case, 
we found that the results were compatible with ade-
nocarcinoma in endoscopic biopsy materials, and 
due to the scantiness of the biopsy materials chorio-
carcinomatous areas were not observed. Thus, larger 
and multiple gastric biopsy samples may be useful 
for definite diagnosis, preoperatively. Because ele-
vated β-hCG levels in these patients are frequently 
observed, the level of β-hCG could be used to follow 
up and monitor the tumor recurrence in a patient, 
especially in post-operative period. However, mild 
elevation might be rarely seen in adenocarcinomas. 
In the presented case, the preoperative levels of 
serum β-hCG were not examined, because preop-
erative β-hCG levels are not examined in our rou-
tine clinical practice. In the post-operative period, 
FIGURE 4. Immunohistochemically, the multinucleated choriocar-
cinomatous syncytiotrophoblast-like cells, stained with beta-Hu-
man Chorionic Gonadotropin antibody (β-hCG), were observed.
FIGURE 3. (A) Microscopically, the tumor had two components. 
The first component was a moderately differentiated adenocar-
cinoma (left side of the image) and the second component were 
solid areas (right side of the image). (B) Microscopic examination 
of the hemorrhagic areas showed highly pleomorphic tumor cells 
and many syncytiotrophoblast-like cells with bizarre nuclei.
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β-hCG level of the patient was only mildly elevated. 
Some authors reported that the elevated β-hCG lev-
els may be associated with poor prognosis (5).
In adenocarcinoma associated with choriocarcino-
matous areas, surgical approach usually shows no 
difference from other classical gastric adenocarcino-
mas. Resection of the tumor mass with clear surgi-
cal margins on gastrectomy specimens are the best 
treatment modalities. Scars and fibrous adhesions 
due to previous operation may be additional diffi-
culties in performing gastrectomy in the patient. On 
the other hand, in another study, resectability ratio 
was not different between the patients with GRC 
and native gastric cancer patients. The literature 
data emphasize the problem of increased lymphatic 
and hematogenous metastasis similar to primary tes-
ticular and uterine choriocarcinomas. Nakao et al. 
reported that approximately 70% of gastric chorio-
carcinomas metastasized to liver or lymph nodes at 
the time of diagnosis (3). However, in our patient, 
we did not observed distant metastasis. Overall 
survival was not found to be different between gas-
tric remnant cancer and proximal gastric cancer 
for native adenocarcinomas (1,6). Nevertheless, a 
small number of reported choriocarcinomatous dif-
ferentiation examples is inadequate to estimate the 
accurate survival rate in order to compare with pure 
gastric choriocarcinomas.
Reviewing the literature, we observed that all 
patients with nonspecific symptoms required 
an upper gastrointestinal endoscopy at the first 
presentation, which was the case in our study as 
well. Our patient was an extremely uncommon 
case of primary remnant gastric adenocarcinoma 
with choriocarcinomatous differentiation. This 
case report emphasizes the importance of periodic 
endoscopic examination in patients with gastric 
resection.
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